As the legalization of cannabis continues to sweep across the globe, regulations are becoming stricter. Equally, licensed producers see the value in investing in quality measures that lend to consumer safety, and build trust with supply chain partners. As you seek to improve the quality and consistency of your product and gain access to new markets, incorporating Good Manufacturing Practice (GMP) is vital.
Vitalis understands the importance of equipment qualification as part of our customers’ overall GMP validation efforts. Coupling the Vitalis GMP systems series with our expert guidance, we work in partnership with you to deliver against all of the technical requirements through our strict equipment qualification process.
*Quick Fact // Vitalis has GMP systems on customer sites across 5 continents and counting*
Blueberries Medical is the leading Latin American Licensed Producer of premium quality cannabis. Through low-cost production and scientific expertise, agricultural advantages, and strategic global relationships, the company is positioned to become a leading international supplier of standardized medicinal-grade cannabis oil extracts and related products. Blueberries Medical is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis.
Blueberries Medical was seeking an extraction manufacturing partner that could not only meet their needs in quality and service but ensure adherence to the strict regulatory standards for their Latin American operations and in anticipation of scaling to new markets.
As international GMP-compliant equipment suppliers to the pharmaceutical, recreational cannabis, and F&B industries, Vitalis holds a deep understanding of GMP regulations around the world. In addition to engineering EU-GMP extractors, our team of experts guided Blueberries Medical through an often complicated process towards achieving EU-GMP qualification for their systems and provided supporting documentation necessary to achieving an extraction equipment qualification.
The publicly-traded company (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) has celebrated a number of successes since launching its operation in 2013. Currently boasting 142 exclusive Colombian cannabis strains with high CBD and THC contents, with all the applicable licenses granted by the Colombian Ministries of Justice and Health, Blueberries Medical has the distinction of being the first Latin American Company to have installed a machine with new stainless-steel extraction vessels that is fully compliant under European Union’s Good Manufacturing Practices (EU-GMP). Most recently, Blueberries Medical gained approval from the Colombian Agricultural Institute (ICA) for the registration of its nine THC dominant strains with the country’s national cultivar registry. They are also positioned as an operation to be EU-GMP compliant in 2021.
To join our growing list of customers with successful GMP operations, reach out today.